These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis. Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552 [TBL] [Abstract][Full Text] [Related]
4. HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma. Liu M; Xiao Y; Tang W; Li J; Hong L; Dai W; Zhang W; Peng Y; Wu X; Wang J; Chen Y; Bai Y; Lin J; Yang Q; Wang Y; Lin Z; Liu S; Xiong J; Wang J; Xiang L Cancer Med; 2020 Jun; 9(11):3932-3943. PubMed ID: 32281284 [TBL] [Abstract][Full Text] [Related]
5. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma. Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169 [TBL] [Abstract][Full Text] [Related]
6. NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer. Chung HH; Lee CT; Hu JM; Chou YC; Lin YW; Shih YL Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707737 [TBL] [Abstract][Full Text] [Related]
7. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2. Zheng YB; Luo HP; Shi Q; Hao ZN; Ding Y; Wang QS; Li SB; Xiao GC; Tong SL World J Gastroenterol; 2014 Jun; 20(21):6515-22. PubMed ID: 24914372 [TBL] [Abstract][Full Text] [Related]
8. Mutually exclusive antiproliferative effect of cell line-specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV-3 vs RMUG-S. Kim M; Suh DH; Choi JY; Lee S; Bae JR; Kim K; No JH; Kim YB J Cell Mol Med; 2020 Mar; 24(5):3246-3251. PubMed ID: 31970886 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation. Bhatlekar S; Viswanathan V; Fields JZ; Boman BM J Cell Physiol; 2018 Feb; 233(2):727-735. PubMed ID: 28464221 [TBL] [Abstract][Full Text] [Related]
10. The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer. Zhang J; Chen B; Wang Y; Liu X; Yan H; Wong KY; Chan AK; Cheung AH; Chow C; Xu D; Wang S; Huang B; Liang L; Ke H; Wong CC; Wu WK; Cheng AS; Yu J; Lo KW; To KF; Kang W J Pathol; 2023 Aug; 260(4):402-416. PubMed ID: 37272544 [TBL] [Abstract][Full Text] [Related]
11. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer. Hu M; Ou-Yang W; Jing D; Chen R Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis. Ran Z; Chen W; Shang J; Li X; Nie Z; Yang J; Li N Gene; 2019 Dec; 721():144097. PubMed ID: 31493507 [TBL] [Abstract][Full Text] [Related]
13. MEIS2 promotes cell migration and invasion in colorectal cancer. Wan Z; Chai R; Yuan H; Chen B; Dong Q; Zheng B; Mou X; Pan W; Tu Y; Yang Q; Tu S; Hu X Oncol Rep; 2019 Jul; 42(1):213-223. PubMed ID: 31115559 [TBL] [Abstract][Full Text] [Related]
14. HOXB9 Expression Correlates with Histological Grade and Prognosis in LSCC. Sun C; Han C; Wang P; Jin Y; Sun Y; Qu L Biomed Res Int; 2017; 2017():3680305. PubMed ID: 28808656 [TBL] [Abstract][Full Text] [Related]
15. Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients. Carbone C; Piro G; Simionato F; Ligorio F; Cremolini C; Loupakis F; Alì G; Rossini D; Merz V; Santoro R; Zecchetto C; Zanotto M; Di Nicolantonio F; Bardelli A; Fontanini G; Tortora G; Melisi D Clin Cancer Res; 2017 Aug; 23(15):4312-4322. PubMed ID: 28298545 [No Abstract] [Full Text] [Related]
16. Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Ji D; Chen Z; Li M; Zhan T; Yao Y; Zhang Z; Xi J; Yan L; Gu J Mol Cancer; 2014 Apr; 13():86. PubMed ID: 24755295 [TBL] [Abstract][Full Text] [Related]
18. c-Myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition. Qu X; Yan X; Kong C; Zhu Y; Li H; Pan D; Zhang X; Liu Y; Yin F; Qin H Cancer Sci; 2019 Oct; 110(10):3183-3196. PubMed ID: 31338937 [TBL] [Abstract][Full Text] [Related]
19. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival. Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083 [TBL] [Abstract][Full Text] [Related]
20. Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer. Meng HM; Zheng P; Wang XY; Liu C; Sui HM; Wu SJ; Zhou J; Ding YQ; Li J Cancer Biol Ther; 2010 Feb; 9(4):295-302. PubMed ID: 20026903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]